The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress

Endocrinology

Volumn 140, Issue 1, 1999, Pages 79-86

  Deak, Terrence ^a   Nguyen, Kien T ^a   Ehrlich, Andrea L ^a   Watkins, Linda R ^a   Spencer, Robert L ^a   Maier, Steven F ^a   Licinio, Julio ^b   Wong, Ma Li ^b   Chrousos, George P ^c   Webster, Elizabeth ^c   Gold, Philip W ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTALARMIN; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; LIPOSYN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONDITIONING; FEAR; FREEZING; HORMONE DETERMINATION; MALE; MUSCLE RIGIDITY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STRESS;

EID: 0032892569     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6415     Document Type: Article

References (58)

1. 1. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 231:1394-1397
2. 2. De Souza EB, Grigoriadis DE 1995 Corticotropin-releasing factor: physiology, pharmacology and role in central nervous system and immune disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp 505-517
3. 3. Owens MJ, Nemeroff CB 1991 Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473
4. 4. Rivier C, Rivier J, Vale W 1982 Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralizarion of corticotropin-releasing factor. Science 218:377-379
5. 5. Brown MR, Fisher LA, Rivier J, Spiess J, Rivier C, Vale W 1982 Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci 30:201-210
6. 6. Berridge CW, Dunn AJ 1986 Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regul Pept 16:83-93
7. 7. Koob GF, Britton KT 1990 Behavioral effects of corticotropin-releasing factor. In: De Souza EG, Nemeroff CB (eds) Corticotropin-releasing Factor: Basic and Clinical Studies of a Neuropeptide. CRC Press, Boca Raton FL, pp 253-266
8. 8. Kalin NH, Shelton SE, Kraemer GW, McKinney WT 1983 Corticotropin-releasing factor administered intraventricularly to rhesus monkeys. Peptides 4:217-220
9. 9. Takahashi LK, Kalin NH, Vanden Burgt JA, Sherman JE 1989 Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav Neurosci 103:648-654
10. 10. Dunn AJ, Berridge DW 1987 Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 27:685-691
11. 11. Valentino RJ, Foote SL, Aston-Jones G 1983 Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363-367
12. 12. Britton KT, Lee G, Vale W, Rivier J, Koob F 1986 Corticotropin-releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res 369:303-306
13. 13. Kalin NH, Sherman JE, Takahashi LK 1988 Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res 457:130-135
14. 14. Korte SM, Korte-Bouws GA, Bohus B, Koob GF 1994 Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiol Behav 56:115-120
15. 15. Swerdlow NR, Britton KT, Koob GF 1989 Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology 115:141-146
16. 16. Butler PD, Weiss JM, Stout JC, Nemeroff CB 1990 Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10:176-183
17. 17. Kalivas PW, Duffy P, Latimer LG 1987 Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242:757-764
18. 18. Liang KC, Lee EHY 1988 Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology 96:232-236
19. 19. Wiersma A, Baauw AD, Bohus B, Koolhaas JM 1995 Behavioural activation produced by CRH but not alpha-helical CRH (CRH-receptor antagonist) when microinfused into the central nucleus of the amygdala under stress-free conditions. Psychoneuroendocrinology 20:423-432
20. 20. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ 1985 Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 5:3189-3203
21. 21. Wong ML, Licinio J, Pasternak KI, Gold PW 1994 Localization of CRH receptor in RNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 135:2275-2278
22. 22. Cummings S, Elde R, Ells J, Lindvall A 1983 Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3:1355-1368
23. 23. Olschowka JA, O'Donohue TL, Mueller GP, Jacobowitz DM 1982 The distribution of corticotropin-releasing factor-like immunoreactive neurons in rat brain. Peptides 3:995-1015
24. 24. Sawchenko PE, Swanson LW 1990 Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies. In: De Souza EB, Nemeroff CB (eds) Corticotropin-releasing Factor: Basic and Clinical Studies of a Neuropeptide. CRC Press, Boca Raton FL, pp 29-52
25. 25. Dunn AJ, Berridge CW 1990 Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety of stress responses? Brain Res Rev 15:71-100
26. 26. Koob GF 1990 Behavioral responses to stress-focus on corticotropin-releasing factor. In: Brown MR, Rivier C, Koob G (eds) Neurobiology and Neuroendocrinology of Stress. Marcel Dekker, New York, pp 255-271
27. 27. Gold PW, Wong J-L, Chrousos GP, Licinio J 1996 Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. Mol Psychiatry 1:257-264
28. 28. Krahn DD, Gosnell BA 1989 CRH: possible role in eating disorders. Psychiatry Med 7:235-245
29. 29. Nemeroff CG 1996 The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:336-342
30. 30. Grillon C, Southwick SM, Charney DS 1996 The psychobiological basis of posttraumatic stress disorder. Mol Psychiatry 1:278-297
31. 31. Chen YPL 1994 International Patient No. wo 94/13676, June 23, 1994
32. 32. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley III FD, Winston EN, Chen YL, Heym J 1996 CP-154,526: a potent and selective non-peptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482
33. 33. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP 1996 In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137:5745-5750
34. 34. Davis M 1992 A neural systems approach to the study of the amygdala, fear, and anxiety. In: Elliott JM, Marsden DJ, Marsden CA (eds) Experimental Approaches to Anxiety and Depression. John Wiley & Sons, Chichester, pp 45-73
35. 35. Fanselow MS, Lester LS 1988 A functional behavioristic approach to aversively motivated behavior: predatory imminence as a determinant of the topography of defensive behavior. In: Bolles RC, Beecher MD (eds) Evolution and Learning. Erlbaum, Hillsdale NJ, pp 185-212
36. 36. Kalin NH, Takahashi LK 1990 Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems. Brain Res 509:80-84
37. 37. Maier SF, Seligman MEP 1976 Learned helplessness: theory and evidence. J Exp Psychol Gen 105:3-46
38. 38. Maier SF 1990 The role of fear in mediating the shuttle escape learning deficit produced by inescapable shock. J Exp Psychol Anim Behav Proc 16:137-150
39. 39. Weiss JM, Simson PG 1985 Neurochemical mechanisms underlying stress-induced depression. In: Field TM, McCabe PM, Schneiderman N (eds) Stress and Coping. Lawrence Erlbaum Associates, Hillsdale NJ, pp 93-117
40. 40. Minor TR, Pelleymounter MA, Maier SF 1988 Uncontrollable shock, forebrain NE, and stimulus selection during choice escape learning. Psychobiology 16:135-146
41. 41. Maier SF, Wiertelak EP, Martin D, Watkins LR 1993 Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 623:321-324
42. 42. Maier SF, Grahn RE, Kalman BA, Sutton LC, Wiertelak EP, Watkins LR 1993 The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock. Behav Neurosci 107:377-388
43. 43. Swiergiel AH, Takahashi LK, Kalin NH 1993 Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res 623:229-234
44. 44. Kita A, Imano K, Nakamura H 1993 Involvement of CRH in the antinociception produced by interleukin-1 on mice. Eur J Pharmacol 237:317-322
45. 45. Pich EM, Heinrichs SC, Rivier C, Miczek KA, Fisher DA, Koob GF 1993 Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats. Psychoneuroendocrinology 18:495-507
46. 46 Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF 1992 Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 531:190-197
47. 47. Campeau S, Davis M 1995 Involvement of subcortical and cortical afferents to the lateral nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 15:2301-2311
48. 48. Fanselow MS, Kim JJ 1994 Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behav Neurosci 108:210-212
49. 49. Miserendino MJ, Sananes CB, Melia KR, Davis M 1990 Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345:716-718
50. 50. Kim JJ, Fanselow MS, DeCola JP, Landeira-Femandez J 1992 Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV. Behav Neurosci 106:591-596
51. 51. Swanson LW, Sawchenko PE, Rivier J, Vale W 1983 The organization of ovine CRF-innunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186
52. 52. Chalmers DT, Lovenberg TW, De Souza EB 1995 Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific sub-cortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350
53. 53. Kalin NH, Takahashi LK, Chen FL 1994 Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res 656:182-186
54. 54. Mansbach RS, Brooks EN, Chen YL 1997 Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. Eur J Pharmacol 323:21-26
55. 55. Maier SF, Ryan SM, Barksdale CM, Kalin NH 1986 Stressor controllability and the pituitary-adrenal system. Behav Neurosci 100:669-674
56. 56. Tilders FJ, Berkenbosch F, Vermes I, Linton EA, Smelek PG 1985 Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Fed Proc 44:155-168
57. 57. Scaccianoce S, Muscolo LA, Cigliana G, Navarra D, Nicolai R, Angelucci L 1991 Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 128:3138-3143
58. 58. De Goeij DC, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJ 1991 Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 53: 150-159